XL092 is an orally active, ATP-competitive inhibitor of multireceptor tyrosine kinases (RTKs), including MET, VEGFR2, AXL and MER, with IC50 values of 15 nM, 1.6 nM, 3.4 nM and 7.2 nM in cell analysis, respectively. XL092 has antitumor activity.
Molecular Weight:
528.53
Purity:
>99.0%
CAS Number:
[2367004-54-2]
Formula:
C29H25FN4O5
Target:
TAM Receptor
* VAT and and shipping costs not included. Errors and price changes excepted